Psychiatry and Psychiatrists – Page 3 – MOSAEC

Acadia Healthcare Says It Faces New Federal Investigations

Federal-State Relations (US) Health and Human Services Department Health Insurance and Managed Care Hospitals Inspectors General Justice Department Psychiatry and Psychiatrists Securities and Commodities Violations Stocks and Bonds

Acadia Healthcare Says It Faces New Federal Investigations

Shares of the company, one of the largest chains of for-profit psychiatric hospitals, were down 25 percent at one point.

By Jessica Silver-Greenberg and Katie Thomas

F.D.A. Approves a New Antipsychotic Drug

Bristol Myers Squibb Company Clinical Trials Dopamine Drugs (Pharmaceuticals) Food and Drug Administration Karuna Therapeutics Inc Psychiatry and Psychiatrists Psychology and Psychologists Regulation and Deregulation of Industry Research Schizophrenia Therapy and Rehabilitation Weight

F.D.A. Approves a New Antipsychotic Drug

Available antipsychotic treatments work by blocking dopamine receptors. The new drug, Cobenfy, takes a different approach.

By Ellen Barry and Christina Jewett

Acadia Hospitals Reach $20 Million Settlement With Justice Dept.

Federal Bureau of Investigation Federal-State Relations (US) Hospitals Justice Department Nursing and Nurses Psychiatry and Psychiatrists Suits and Litigation (Civil) Whistle-Blowers

Acadia Hospitals Reach $20 Million Settlement With Justice Dept.

The F.B.I. is also investigating the large chain of psychiatric hospitals for holding patients longer than what is medically necessary.

By Katie Thomas and Jessica Silver-Greenberg

How a Leading Chain of Psychiatric Hospitals Traps Patients

Emergency Medical Treatment Hospitals Medicine and Health Mental Health and Disorders Psychiatry and Psychiatrists Psychology and Psychologists

How a Leading Chain of Psychiatric Hospitals Traps Patients

Acadia Healthcare is holding people against their will to maximize insurance payouts, a Times investigation found.

By Jessica Silver-Greenberg and Katie Thomas